Innovation in biotechnology: Moving from academic research to product developmentthe case of biosensors

Critical Reviews in Biotechnology

Volumn 30, Issue 2, 2010, Pages 79-98

  Siontorou, Christina G ^a   Batzias, Fragiskos A ^a  

^a UNIVERSITY OF PIRAEUS   (Greece)

Author keywords

Biosensors; Decision making; Knowledge acquisition; Knowledge management; Technology transfer

Indexed keywords

ACADEMIC RESEARCH; BIOTECHNOLOGY INDUSTRY; BUSINESS MODELS; CONTEXTUALIZE; CONTINUOUS INNOVATION; INDUSTRIAL USE; INDUSTRY ALLIANCES; KNOWLEDGE MANAGEMENT TECHNOLOGY; KNOWLEDGE TRANSFER; MARKET DEMAND; METHODOLOGICAL APPROACH; MULTIDISCIPLINARY COLLABORATION; TECHNOLOGICAL CHANGE; TRANSFORMATION PROCESS; TRANSITION MECHANISM;

BIOTECHNOLOGY; COMMERCE; DECISION MAKING; INDUSTRIAL APPLICATIONS; INDUSTRY; INNOVATION; KNOWLEDGE ACQUISITION; KNOWLEDGE MANAGEMENT; RESEARCH; TECHNOLOGICAL FORECASTING; TECHNOLOGY TRANSFER;

BIOSENSORS;

CARBON NANOTUBE;

BIOSENSOR; BIOTECHNOLOGICAL PRODUCTION; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; CONCEPTUAL FRAMEWORK; DECISION MAKING; INTERDISCIPLINARY COMMUNICATION; KNOWLEDGE MANAGEMENT; MARKETING; MEDICAL RESEARCH; PORTABLE EQUIPMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PRODUCT DEVELOPMENT; REVIEW; SCALE UP;

BIOMEDICAL RESEARCH; BIOSENSING TECHNIQUES; BIOTECHNOLOGY; DECISION MAKING; MARKETING;

EID: 77952870463     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.3109/07388550903427298     Document Type: Review

References (62)

1. Alocilja EC, Radke SM. 2003. Market analysis of biosensors for food safety. Biosens Bioelectron 18: 841-846.
2. Batzias AF, Batzias FA. 2004. Fuzzy multi-criteria choice of instrumental methods for measuring physical quantities\application in the case of dielectric aluminium anodic oxide flms. Proc IEEE Instrument Meas Technol 3: 2217-2222.
3. Batzias FA, Marcoulaki EC. 2002. Restructuring the keywords interface to enhance CAPE knowledge via an intelligent agent. Comp Aided Chem Eng 10: 829-834.
4. Batzias FA, Siontorou CG. 2005. Investigating the causes of biosensor SNR decrease by means of fault tree analysis. IEEE Trans Instrum Meas 54: 1395-1406.
5. Brans JP, Vincke Ph, Mareschal B. 1986. How to select and how to rank projects: Te PROMETHEE method. Europ J Oper Res 24: 228-238.
6. Breznitz SM, O'Shea RP, Allen TJ. 2008. University commercialization strategies in the development of regional bioclusters. J Prod Innov Manag 25: 129-142.
7. Contractor FM, Sharma P, Dash N, Lupetin AR, Schapiro RL. 1987. Extension of hepatic metastatic tumor along a biliary drainage catheter tract: case report. Cardiovasc Intervent Radiol 10: 303-304.
8. Costa C, Fontes M, Heitor MV. 2004. A methodological approach to the marketing process in the biotechnology-based companies. Indust Market Manag 33: 403-418.
9. D'Orazio P. 2003. Biosensors in clinical chemistry. Clin Chim Acta 334: 41-69.
10. Dumett M, Rosen G, Sabat J, Shaman A, Tempelman L, Wang C, Swift R. 2008. Deconvolving an Estimate of Breath Measured Blood Alcohol Concentration from Biosensor Collected Transdermal Ethanol Data. Appl Math Comput 196: 724-743.
11. Fallberg P-O, Brynö A. 1998. Tey just keep on working Biacore J 5: 17-18.
12. Faulkner DO, De Rond M. 2000. Cooperative Strategy: Economic, Business and Organizational Issues. Oxford, UK: Oxford University Press.
13. Fernandez D, Chow M. 2005. Intellectual property strategy in bioinformatics and biochips. Biosens Bioelectron 21: 197-200.
14. George G, Zahra SA, Wood Jr., DR. 2002. the efects of business-university alliances on innovative output and fnancial performance: a study of publicly traded biotechnology companies. J Business Vent 17: 577-609.
15. Guiochon GA, Beaver LA. 2004. Progress and future of instrumental analytical chemistry applied to the environment. Analyt Chim Acta 524: 1-14.
16. Hawdon JM, Platt MP, Aynsley-Green A. 1993. Neonatal hypoglycaemia\blood glucose monitoring and baby feeding. Midwifery 9: 3-6.
17. Khilji SE, Mroczkowski T, Bernstein B. 2006. From invention to innovation: toward developing an integrated innovation model for biotech frms. J Prod Innov Manag 23: 528-540.
18. Kissinger PT. 2005. Biosensors-a perspective. Biosens Bioelectron 20: 2512-2516.
19. Kumar CSSR. 2007. Nanomaterials for Biosensors. Germany: Wiley-VCH.
20. Lee CH, Wang SC, Yuan CJ, Wen MF, Chang KS. 2007. Comparison of ampero-metric biosensors fabricated by palladium sputtering, palladium elec-trodeposition and Nafon/carbon nanotube casting on screen-printed carbon electrodes. Biosens Bioelectron 22: 877-884.
21. Levin M. 2004. Cross-boundary learning systems. Syst Pract Action Res 17: 151-159.
22. Lim SH, Wei J, Lin J, Li Q, Kuayou J. 2005. A glucose biosensor based on elec-trodeposition of palladium nanoparticles and glucose oxidase onto Nafon-solubilized carbon nanotube electrode. Biosens Bioelectron 20: 2341-2346.
23. Lindner E, Gyurcsányi RE, Buck RP 2002. Membranes in electroanalytical chemistry: membrane-based chemical and biosensors. In Hubbard AT (ed.), Encyclopedia of Surface & Colloid Science. NY: Marcel Dekker.
24. Lynch JM. 1998. Terrestrial biotechnology. Curr Opin Biotechnol 9: 247-251.
25. Mangematin V, Lemarié S, Boissin J-P, Catherine D, Corolleur F, Coronini C, Trommetter M. 2003. Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France. Res Policy 32: 621-638.
26. Marot M, Selsky JW, Hart W, Reddy P. 2005. Research teams in an Australian biotechnology feld: how intellectual property infuences collaboration. In: Advances in Interdisciplinary Studies of Work Teams (pp. 1-31), Vol.11. Elsevier Ltd. Editors: M.M. Beyerlein, S.T. Beyerlein, F. A. Kennedy. Publishing Place: UK
27. Mirsky VM. 2004. Ultrathin Electrochemical Chemo-and Biosensors: Technology and Performance. Springer Series on Chemical Sensors and Biosensors, Vol.2. Berlin: Springer.
28. Newman JD, Turner AP. 2005. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron 20: 2435-2453.
29. Newman JD, Tigwell LJ, Turner APF, Warner PJ. 2004. Biosensors\A Clearer View. UK: Cranfeld University.
30. Nikolelis DP, Siontorou CG. 1996. Flow injection monitoring and analysis of mixtures of simazine, atrazine, and propazine using flter-supported bilayer lipid membranes. Electroanalysis 8: 907-912.
31. Nikolelis DP, Simantiraki MG, Siontorou CG, Toth K. 2005. Flow injection analysis of carbofuran in foods using air stable lipid flm based acetyl-cholinesterase biosensor. Analyt Chim Acta 537: 169-177.
32. Nonaka I, Umemoto K, Senoo D. 1996. From information processing to knowledge creation: a paradigm shift in business management. Technol Soc 18: 203-218.
33. Oberlies NH, Kroll DJ. 2004. Camptothecin and taxol: historic achievements in natural products research. J Nat Prod 67: 129-135.
34. Paladino A. 2007. Investigating the drivers of innovation and new product success: a comparison of strategic orientations. J Prod Innov Manag 24: 534-553.
35. Pisano GP. 1989. Using equity participation to support exchange evidence from the biotechnology industry. J Law Econ Org 5:109-126.
36. Powell W, Koput K, Smith-Doerr L. 1996. Inter-organizational collaboration and the locus of innovation: networks of learning in biotechnology. Admin Sci Quart 41: 116-145.
37. Ramsay G. 1998. Commercial biosensors: applications to clinical, bioproc-ess, and environmental samples. In: Chemical Analysis: A Series of Monographs on Analytical Chemistry and Its Applications. New York: Wiley-Interscience.
38. Rao LV, Jakubiak F, Sidwell JS, Winkelman JW, Snyder ML. 2005. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta 356: 178-183.
39. Razumiene J, Vilkanauskyte A, Gureviciene V, Barkauskas J, Meskys R, Laurinavicius V. 2006. Direct electron transfer between PQQ dependent glucose dehydrogenases and carbon electrodes: an approach for electrochemical biosensors. Electrochim Acta 51: 5150-5156.
40. Reuer JJ, Zollo M, Singh H. 2002. Post-formation dynamics in strategic alliances. Strat Manag J 23: 135-151.
41. Rich RL, Myszka DG. 2001. Survey of the year 2000 commercial optical biosensor literature. J Mol Recognit 14: 273-294.
42. Rodriguez-Mozaz S, Lopez de Alda MJ, Barceló D. 2006. Biosensors as useful tools for environmental analysis and monitoring. Anal Bioanal Chem 386: 1025-1041.
43. Salomo S, Weise J, Gemünden G. 2007. NPD planning activities and innovation performance: the mediating role of process management and the moderating efect of product innovativeness. J Prod Innov Manag 24: 285-302.
44. Salter AJ, Martin BR. 2001. Te economic benefts of publicly funded basic research: a critical review. Res Policy 30: 509-532.
45. Scheller FW, Schubert F, Renneberg R, Müller H-G, Jänchen M, Weise H. 1985. Biosensors: trends and commercialization. Biosensors 1: 135-160.
46. Schuvailo OM, Soldatkin OO, Lefebvre A, Cespuglio R, Soldatkin AP. 2006. Highly selective microbiosensors for in vivo measurement of glucose, lactate and glutamate. Anal Chim Acta 573-574: 110-116.
47. Siontorou CG, Nikolelis DP, Krull UJ. 2000. Flow injection monitoring and analysis of mixtures of hydrazine compounds using flter-supported bilayer lipid membranes with incorporated DNA. Anal Chem 72: 180-186.
48. Siu W-S, Bao Q. 2008. Network strategies of small Chinese high-technology frms: a qualitative study. J Prod Innov Manag 25: 79-102.
49. Stuart TE, Ozdemir SZ, Ding WW. 2007. Vertical alliance networks: the case of university-biotechnology-pharmaceutical alliance chains. Res Policy 36: 477-498.
50. Tévenot DR, Toth K, Durst RA, Wilson GS. 1999. Electrochemical biosensors: recommended defnition and classifcation. Pure Appl Chemi 71: 2333-2348.
51. Tompson E, Vonortas NS. 2005. Biotechnology evolution and regulation of pharmaceuticals. In:Carruth R (ed.), Global Governance of the Pharmaceuticals Industries: Transatlantic and Trilateral Regulatory Harmonization and Multilateral Policy Cooperation for Drug Safety. Te George Washington University, Ch. 9.
52. Tien H-T, Ottova-Leitmannova A. 2003. Planar Lipid Bilayers (BLMs) and Teir Applications. Amsterdam: Elsevier.
53. Todt O, Gutiérrez-Gracia A, Fernández de Lucio I, Castro-Martínez E. 2007. Te regional dimension of innovation and the globalization of science: the case of biotechnology in a peripheral region of the European Union. R&D Manag 37: 65-74.
54. Toko K. 2000. Biomimetic Sensor Technology. UK: Cambridge University Press.
55. Tschmelak J, Kumpf M, Käppel N, Proll G, Gauglitz G. 2006. Total internal refectance fuorescence (TIRF) biosensor for environmental monitoring of testosterone with commercially available immunochemistry: antibody characterization, assay development and real sample measurements. Talanta 69: 343-350.
56. Tschmelak J, Proll G, Riedt J, Kaiser J, Kraemmer P, Bárzaga L, Wilkinson JS, Hua P, Hole JP, Nudd R, Jackson M, Abuknesha R, Barceló D, Rodriguez-Mozaz S, de Alda MJ, Sacher F, Stien J, Slobodník J, Oswald P, Kozmenko H, Korenková E, Tóthová L, Krascsenits Z, Gauglitz G. 2005. Automated water analyser computer supported system (AWACSS) Part I: Project objectives, basic technology, immunoassay development, software design and networking. Biosens Bioelectron 20: 1499-1508.
57. Tseng TY, Klein CM. 1989. New algorithm for the ranking procedure in fuzzy decision making", IEEE Trans Syst Man Cybernet 19: 1289-1296.
58. U.S. Food Drug Administration 1997. Review criteria assessment of portable blood glucose monitoring in vitro diagnostic devices using glucose oxi-dase, dehydrogenase or hexokinase methodology, draft document.
59. Vote DA, Doar O, Moon RE, Tofaletti JG. 2001. Blood glucose meter performance under hyperbaric oxygen conditions. Clin Chim Acta 305: 81-87.
60. Wang J. 2001. Glucose biosensors: 40 years of advances and challenges. Electroanalysis 13: 983-988.
61. Wisniewski N, Moussy F, Reichert WM. 2000. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 366: 611-621.
62. ▲des for sensor applications: a review. Talanta 65: 1102-1109.